|
|||||
|
Search
About Euroscicon News
Euroscicon host unbiased events where scientists from many fields can participate and offer their own experiences of technology that can help improve the experiments of others. Each event is an opportunity for industry and academia to share discussion, new bonds and new ideas for the future. This site is a listing of news from Euroscicon plus information from our partners and friends. It contains current information on selected events, details of our prize draw winners, press releases about new reagents and technologies, job offers and information on occasional discounted registrations. The best news is that anyone subscribed to our e-newsletter will automatically receive the articles posted to this website directly in their inbox. We are constantly changing and improving this website so please do come back and if you would like us to post an article, event announcement or job description do get in touch Month Archive
Sponsors
AllConferences.Com Directory of Conferences, conventions, exhibits, seminars, workshops, events, trade shows and business meetings. Includes calendar, dates, location, web site, contact and registration information. |
Wednesday, July 1
by
Dr Astrid Englezou
on Wed 01 Jul 2009 02:08 PM BST
We are pleased to announce that a report from our Nanotoxicology meeting, which took place in February of this year, has been published in Nanomedicine more »
Saturday, June 20
Friday, June 19
by
Dr Astrid Englezou
on Fri 19 Jun 2009 10:48 AM BST
We are pleased to announce that a report from our meeting 'Improving Immunohistochemistry' has been published in The Biomedical Scientist. more »
Thursday, June 18
by
sharac
on Thu 18 Jun 2009 07:57 PM BST
Scientists in the Departments of Medicine and Molecular Genetics at the Albert Einstein College of Medicine are isolating proteins from the serum of Ashkenazi Jewish centenarians, their offspring and age-matched offspring controls. The proteins are extracted and then run on 1D gels stained with Coomassie blue and are also transferred onto Western blots, probed with different antibodies and then stained with Horse Radish Peroxidase. The 1D protein gels and Western blots produced are imaged and analysed using a Dyversity system, enabling researchers to detect specific proteins and establish if these are connected with a longer life. more »
Tuesday, June 16
Monday, June 15
by
Dr Astrid Englezou
on Mon 15 Jun 2009 08:00 AM BST
The chair for this meeting will be Dr David Whitehouse. The agenda is under construction. If you have any queries or are interested in speaking at this event please contact meetingsproducer@euroscicon.com. The meeting has CPD approval. more »
Wednesday, June 10
by
EurosciconWebmaster
on Wed 10 Jun 2009 01:00 PM BST
This site has been designed specifically for PhD students and for those thinking about doing a PhD more »
Monday, June 8
by
Dr Astrid Englezou
on Mon 08 Jun 2009 08:00 AM BST
We are pleased to announce this follow up meeting to our 2008 'Molecular farming- plant biologicals' event. The meeting chair is Professor Julian K-C. Ma, Hotung (Chair of Molecular Immunology, St. George's, University of London) and the meeting will have CPD approval. more »
Monday, June 1
by
Dr Astrid Englezou
on Mon 01 Jun 2009 09:00 AM BST
We are pleased to announce this follow up meeting to our successful Developments in Cell Culture Technology to enhance Cell Growth In Vitro meeting. The chair will be Dr Stefan Przyborski and the meeting has CPD approval. more »
Friday, May 22
by
Dr Astrid Englezou
on Fri 22 May 2009 12:16 PM BST
"Huge technological advances have been made recently in the genomic and post-genomic analyses of pathogens and disease. To exploit these advances for the production of successful recombinant vaccines we need strategies to select appropriate molecules and to deliver them appropriately to stimulate protective immune responses. This meeting will explore both candidate discovery and the tools for delivering vaccines effectively". Meeting Chair: Dr Alasdair Nisbet, Moredun Research Institute, UK. The meeting has CPD approval. more »
Wednesday, May 20
Friday, May 15
by
Dr Astrid Englezou
on Fri 15 May 2009 10:00 AM BST
"This meeting will provide an update on phenotypic and functional aspects of regulatory T cells, aiming to inform, educate and entertain. Presentations will be delivered by world-class leaders in their respective fields and a lively discussion will follow each series of talks. Coupled with the pleasant ambience and modern facilities of the venue, this event promises to be one not to be missed" Meeting Chair: Dr Oliver Garden,The Royal Veterinary College & Imperial College London, UK. The meeting has CPD approval. more »
Tuesday, May 12
by
sharac
on Tue 12 May 2009 05:28 PM BST
Asterand plc (LSE: ATD), a leading provider of human tissue and services to scientists engaged in drug discovery research, announces that it has entered into a collaborative agreement with Abcam plc (AIM: ABC), the rapidly growing bioscience company that markets antibodies via its own online catalogue. Asterand will undertake the validation and characterisation of a selected group of Abcam antibodies for immuno-histochemistry applications using Asterand’s PhaseZERO® Human Tissue Services platform. more »
Sunday, May 10
Friday, May 8
by
Dr Astrid Englezou
on Fri 08 May 2009 11:00 AM BST
The agenda for this event is under construction. If you have any queries or are interested in speaking at this event please contact meetingsproducer@euroscicon.com. The meeting has CPD approval more »
Friday, May 1
by
Dr Astrid Englezou
on Fri 01 May 2009 10:25 AM BST
"Once you can produce it in a flask, what next? The focus of this meeting will be on techniques for the bioproduction of usable quantities of biologic materials, specifically recombinant proteins, monoclonal antibodies, cytokines viruses and other secreted cellular products from eukaryotic cells. Topics covered will include expression systems, mammalian vs. insect vs. other, constituitive vs. transient expression, cell culture medium considerations and culture devices for scale-up that can be used in any laboratory. This meeting should show the fastest pathway from discovery to proof of principle and the production of 100 mgs to several grams of product" Meeting Chair: Dr John J.S. Cadwell, President and CEO, FiberCell Systems Inc, USA. The meeting has CPD approval. more »
Wednesday, April 29
by
Dr Astrid Englezou
on Wed 29 Apr 2009 03:48 PM BST
Four clearly distinct, focused sessions are planned.. Session A will cover different applications of ELISPOT that are unique to the technique and should be of general interest because it can be applied to all fields of study in which ELISPOT is used. Session B will be dedicated to ELISPOT standardization, harmonization and validation. There are three major multicenter programs ongoing and these will provide a briefing on the progress they have made. Sessions C and D are assigned to the ELISPOT reagent and instrument manufacturers to share new developments on their front. Session E is dedicated to questions and answer. Participants will be asked to submit questions before the meeting, and also to ask questions ad hoc – these questions will be discussed. The meeting has CPD approval. more »
by
sharac
on Wed 29 Apr 2009 03:00 PM BST
Are you measuring or want to measure cytokines ? , trying to optimise your technique or do you want just to make sure you are going about it the right way?
This meeting aims to summarise some of the options open to you and to discuss which techniques best suit your requirements. A series of presentations from experts working in the academic, clinical and commercial sectors will compare recent developments in technologies ranging from relatively “low-tech” assays such as ELISA, Elispot and bioassays through to the “high-tech” platform technologies of various multiplex cytokine detection systems. Their use in basic science, R&D and translational research will be discussed more »
Tuesday, April 28
Monday, April 27
by
Dr Astrid Englezou
on Mon 27 Apr 2009 11:56 AM BST
"Significant advances in our understanding of the innate immune recognition have been made in the last decade following the identification of three families of pattern recognition receptors: Toll-like receptors (TLRs), NOD-like receptors (NLRs) and RIG-I-like receptors (RLRs). TLRs are pattern recognition receptors that detect motifs or signatures from bacteria, viruses, protozoa and fungi. NLRs detect mainly intracellular bacteria and RLRs detect viral genome. These three families of pattern recognition receptors comprise the front line of defence that the host possesses against microbial pathogens. The aim of this meeting is to provide an overview of these three families of receptors and provide the most recent advances in the area of innate immune pattern recognition". Chairs: Dr Martha Triantafilou/Dr Kathy Triantafilou, University of Sussex, UK more »
Monday, April 20
Thursday, April 16
by
sharac
on Thu 16 Apr 2009 08:28 AM BST
LGC Standards has opened its first office in Beijing, China, signalling a milestone in the company’s international development. The new office will enable the company to bring its range of laboratory quality products and services to the Chinese market. more »
Friday, April 10
Friday, March 27
by
Dr Astrid Englezou
on Fri 27 Mar 2009 11:53 AM GMT
The chair of our meeting on 19th June this year, will be Dr Richard Williams from Imperial College. Our exciting agenda includes many well renowned speakers... more »
Wednesday, March 25
by
Dr Astrid Englezou
on Wed 25 Mar 2009 08:00 AM GMT
This meeting will explore the new technological advances and research currently being undertaken to irradicate these neglected diseases and discuss the greater implications these will have to global public health". Meeting Chair: Professor P.K. Das, University of Amsterdam, The Netherlands . The meeting has CPD approval. THE FEE FOR THIS MEETING HAS BEEN REDUCED BY 30% (if you have not already registered). more »
Monday, March 23
by
Dr Astrid Englezou
on Mon 23 Mar 2009 04:55 PM GMT
We are pleased to announce that a report from our meeting ‘Flow cytometry: recent advances in techniques and instrumentation’ has been published in The Biomedical Scientist. more »
Friday, March 20
by
sharac
on Fri 20 Mar 2009 07:00 PM GMT
Nature Biotechnology devotes pages specifically to in-depth analysis of issues concerning biotechnology intellectual property case law and policy, together with breaking news on patents. more »
by
Dr Astrid Englezou
on Fri 20 Mar 2009 08:00 AM GMT
The Ontario Genomics Institute (OGI) has invested in a London, Ontario start-up company, Cytognomix, to enable the commercial development of novel cytogenetic DNA probes that detect and pinpoint anomalies in the genome at higher resolution than is currently routinely possible.. more »
Tuesday, March 17
by
Dr Astrid Englezou
on Tue 17 Mar 2009 09:00 AM GMT
Agilent Technologies Inc. has announced the introduction of its SurePrint G3 Microarrays.... more »
Friday, March 13
by
Dr Astrid Englezou
on Fri 13 Mar 2009 12:00 PM GMT
This popular annual event, now in its 6th year, is dedicated to the technique of immunohistochemistry and in situ hybridisation.“This exciting meeting has been created to merge the need for technical-based updates in the areas of immunohistochemistry, clinical histopathology and in situ hybridisation. Academic speakers from each area of research will give technical presentationsof 30 minute duration interspersed with 15 minute scientific contributions from commercial speakers”. Meeting Chair: Dr Will Howat, Cambridge Research Institute, Cancer Research UK. The meeting has CPD approval. more »
Tuesday, March 10
Monday, March 9
by
Dr Astrid Englezou
on Mon 09 Mar 2009 10:00 AM GMT
Agilent Technologies, Inc., and Markes International Limited today announced a strategic alliance for global distribution and market development of analytical thermal desorption (TD) instruments used with gas chromatography (GC) and gas chromatography/mass spectrometry (GC/MS) systems more »
|
|
|||
|
|||||
